Nidan Laboratories and Healthcare Balance Sheet Health
Financial Health criteria checks 4/6
Nidan Laboratories and Healthcare has a total shareholder equity of ₹673.1M and total debt of ₹117.7M, which brings its debt-to-equity ratio to 17.5%. Its total assets and total liabilities are ₹834.5M and ₹161.4M respectively. Nidan Laboratories and Healthcare's EBIT is ₹27.8M making its interest coverage ratio -4.2. It has cash and short-term investments of ₹28.0M.
Key information
17.5%
Debt to equity ratio
₹117.65m
Debt
| Interest coverage ratio | -4.2x |
| Cash | ₹27.95m |
| Equity | ₹673.07m |
| Total liabilities | ₹161.44m |
| Total assets | ₹834.52m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: NIDAN's short term assets (₹108.3M) do not cover its short term liabilities (₹111.4M).
Long Term Liabilities: NIDAN's short term assets (₹108.3M) exceed its long term liabilities (₹50.0M).
Debt to Equity History and Analysis
Debt Level: NIDAN's net debt to equity ratio (13.3%) is considered satisfactory.
Reducing Debt: NIDAN's debt to equity ratio has reduced from 311.7% to 17.5% over the past 5 years.
Debt Coverage: NIDAN's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: NIDAN earns more interest than it pays, so coverage of interest payments is not a concern.